Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Metabolic, Immune, and Neurotrophic Markers in the Etiology of Eating Disorders Using Neonatal Bloodspots

NCT07016334 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07016334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07016334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Metabolic, Immune, and Neurotrophic Markers in the Etiology of Eating Disorders Using Neonatal Bloodspots
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2022
Completion date
December 31, 2027
Enrollment
3,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eating disorders